Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Oncology
Description:
Welcome to our podcast, where today we discuss lung cancer—one of the most common and serious cancers worldwide. The primary risk factor for lung cancer is smoking, but exposure to second-hand smoke, radon gas, asbestos, and air pollution can also increase your risk. Family history and certain genetic factors may play a role as well. The good news is that many lung cancer cases can be prevented. Quitting smoking, avoiding exposure to harmful substances, and choosing a healthy lifestyle with regular exercise all help lower your risk. Early detection is vital, so speak to your healthcare provider if you have concerns. Remember, knowledge and proactive choices are your best defence.
See More Webinars @ Hidoc Webinars
1.
Durvalumab Wins FDA Approval in Limited-Stage SCLC
2.
Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?
3.
Clinical trial sees dramatic results using radiation to treat breast cancer
4.
Can taking vitamin D supplements every day lower the mortality rate from cancer?
5.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
1.
Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion
2.
Surgical Innovation Using Hematopoietic Reserve Preservation During Major Surgery
3.
Understanding Fibrosarcoma: What You Need to Know
4.
Precision Supportive Oncology: Managing Immune Toxicity, Treatment-Related Critical Illness and Long-Term Quality of Life
5.
The Growing Crisis of Aplastic Anemia: A Call for Action
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Expert Perspectives on Hematology
3.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Managing Common Side Effects During Cancer Treatment
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge